134 related articles for article (PubMed ID: 35149390)
1. A pharmacogenomic investigation of the cardiac safety profile of ondansetron in children and pregnant women.
Drögemöller BI; Wright GEB; Trueman J; Shaw K; Staub M; Chaudhry S; Miao F; Higginson M; Groeneweg GSS; Brown J; Magee LA; Whyte SD; West N; Brodie SM; Jong G'; Israels S; Berger H; Ito S; Rassekh SR; Sanatani S; Ross CJD; Carleton BC
Biomed Pharmacother; 2022 Apr; 148():112684. PubMed ID: 35149390
[TBL] [Abstract][Full Text] [Related]
2. Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCT.
Robson S; McParlin C; Mossop H; Lie M; Fernandez-Garcia C; Howel D; Graham R; Ternent L; Steel A; Goudie N; Nadeem A; Phillipson J; Shehmar M; Simpson N; Tuffnell D; Campbell I; Williams R; O'Hara ME; McColl E; Nelson-Piercy C
Health Technol Assess; 2021 Nov; 25(63):1-116. PubMed ID: 34782054
[TBL] [Abstract][Full Text] [Related]
3. Cardiac safety concerns for ondansetron, an antiemetic commonly used for nausea linked to cancer treatment and following anaesthesia.
Doggrell SA; Hancox JC
Expert Opin Drug Saf; 2013 May; 12(3):421-31. PubMed ID: 23578248
[TBL] [Abstract][Full Text] [Related]
4. Ondansetron Safety Regarding Prolong QTc for Children with Head Trauma.
Assaad R; Pratt RE; Wrotniak BH; Qiao H; Territo HM
J Emerg Med; 2023 May; 64(5):647-651. PubMed ID: 37061459
[TBL] [Abstract][Full Text] [Related]
5. Effect of domperidone, ondansetron, olanzapine-containing antiemetic regimen on QT
Kamath A; Rai KM; Shreyas R; Saxena PUP; Banerjee S
Sci Rep; 2021 Jan; 11(1):445. PubMed ID: 33431995
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy - results of a non-interventional observation study.
Willier S; Cabanillas Stanchi KM; von Have M; Binder V; Blaeschke F; Feucht J; Feuchtinger T; Döring M
BMC Cancer; 2019 Nov; 19(1):1118. PubMed ID: 31730451
[TBL] [Abstract][Full Text] [Related]
7. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron.
Charbit B; Albaladejo P; Funck-Brentano C; Legrand M; Samain E; Marty J
Anesthesiology; 2005 Jun; 102(6):1094-100. PubMed ID: 15915019
[TBL] [Abstract][Full Text] [Related]
8. Palonosetron is nonsuperior to ondansetron in acute phase but provides superior antiemetic control in delayed phase for pediatric patients administered highly emetogenic chemotherapy.
Tan J; Wang S; Liang X; Li CC; Zhang J; Zhao Z; Kong XR; Deng X; Peng L; Yang C
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28941006
[TBL] [Abstract][Full Text] [Related]
9. Effect of Intravenous Ondansetron on the QT Interval of Patients' Electrocardiograms.
Krammes SK; Jacobs T; Clark JM; Lutes RE
Pediatr Emerg Care; 2018 Jan; 34(1):38-41. PubMed ID: 27261956
[TBL] [Abstract][Full Text] [Related]
10. Ondansetron Use During Pregnancy: Birth Defects and Obstetric Outcomes.
Masarwe S; Shvartsur R; Hadar E; Betesh-Abay B; Peleg N; Azab AN
Clin Nurs Res; 2023 May; 32(4):705-711. PubMed ID: 36912091
[TBL] [Abstract][Full Text] [Related]
11. Effect of Ondansetron on QT Interval in Patients Cared for in the PICU.
Trivedi S; Schiltz B; Kanipakam R; Bos JM; Ackerman MJ; Ouellette Y
Pediatr Crit Care Med; 2016 Jul; 17(7):e317-23. PubMed ID: 27387786
[TBL] [Abstract][Full Text] [Related]
12. Ventricular tachycardia after ondansetron administration in a child with undiagnosed long QT syndrome.
McKechnie K; Froese A
Can J Anaesth; 2010 May; 57(5):453-7. PubMed ID: 20204717
[TBL] [Abstract][Full Text] [Related]
13. The effect of oral ondansetron on QT interval in children with acute gastroenteritis; a retrospective observational study.
Yang H; Jeon W; Ko Y; Jeong S; Lee J
BMC Pediatr; 2021 Nov; 21(1):501. PubMed ID: 34758763
[TBL] [Abstract][Full Text] [Related]
14. [Ondansetron versus droperidol. Postoperative treatment against nausea and vomiting. Comparison of action, adverse effects and acceptance by gynecologic inpatients].
Heim C; Münzer T; Listyo R
Anaesthesist; 1994 Aug; 43(8):504-9. PubMed ID: 7978173
[TBL] [Abstract][Full Text] [Related]
15. The effect of sevoflurane and ondansetron on QT interval and transmural dispersion of repolarization in children.
Lee JH; Park YH; Kim JT; Kim CS; Kim HS
Paediatr Anaesth; 2014 Apr; 24(4):421-5. PubMed ID: 24372925
[TBL] [Abstract][Full Text] [Related]
16. Ondansetron-induced QT prolongation among various age groups: a systematic review and meta-analysis.
Singh K; Jain A; Panchal I; Madan H; Gupta A; Sharma A; Gupta S; Kostojchin A; Singh A; Sandhu IS; Mittal J; Bhogal L; Kolli ST; Bejugam VR; Chaturvedi S; Bhalla A; Piplani S
Egypt Heart J; 2023 Jul; 75(1):56. PubMed ID: 37395900
[TBL] [Abstract][Full Text] [Related]
17. The effects of ondansetron versus dexamethasone on electrocardiographic markers of ventricular repolarization in children undergoing cochlear implant.
Safaeian R; Hassani V; Asghari A; Mohseni M; Ashraf H; Koleini ZS
Int J Pediatr Otorhinolaryngol; 2020 May; 132():109896. PubMed ID: 32032916
[TBL] [Abstract][Full Text] [Related]
18. Intravenous Ondansetron and the QT Interval in Adult Emergency Department Patients: An Observational Study.
Moffett PM; Cartwright L; Grossart EA; O'Keefe D; Kang CS
Acad Emerg Med; 2016 Jan; 23(1):102-5. PubMed ID: 26720490
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups.
Fortney JT; Gan TJ; Graczyk S; Wetchler B; Melson T; Khalil S; McKenzie R; Parrillo S; Glass PS; Moote C; Wermeling D; Parasuraman TV; Duncan B; Creed MR
Anesth Analg; 1998 Apr; 86(4):731-8. PubMed ID: 9539593
[TBL] [Abstract][Full Text] [Related]
20. The use of ondansetron in the treatment of nausea and vomiting associated with acetaminophen poisoning.
Clark RF; Chen R; Williams SR; Johnson CL; Harchelroad F
J Toxicol Clin Toxicol; 1996; 34(2):163-7. PubMed ID: 8618249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
